Literature DB >> 14598884

Prediction of nodal spread of breast cancer by using artificial neural network-based analyses of S100A4, nm23 and steroid receptor expression.

S R Grey1, S S Dlay, B E Leone, F Cajone, G V Sherbet.   

Abstract

The expression of tumour promoter gene S100A4, metastasis suppressor gene nm23, oestrogen and progesterone receptors, and tumour grade and size have been investigated for their potential to predict breast cancer progression. The molecular and cellular data have been analysed using artificial neural networks to determine the potential of these markers to predict the presence of metastatic tumour in the regional lymph nodes. This study shows that tumour grade and size are poor predictors. The relative expression of S100A4 and nm23 genes is the single most effective predictor of nodal status. Inclusion of oestrogen- and progesterone-receptor status with tumour grade and size markers improves prediction; however, there may be some overlap between steroid receptors and molecular markers. This study also underscores the power of artificial neural network techniques to predict the potential of primary breast cancers to spread to axillary lymph nodes. This could aid the clinician in determining whether invasive procedures of axially node dissection can be obviated and whether conservative forms of treatment might be appropriate in the management of the patient.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14598884     DOI: 10.1023/a:1025846019656

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  36 in total

1.  The Nottingham Prognostic Index in primary breast cancer.

Authors:  M H Galea; R W Blamey; C E Elston; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 2.  Oestrogen receptors and breast cancer: current status.

Authors:  R A Hawkins; M M Roberts; A P Forrest
Journal:  Br J Surg       Date:  1980-03       Impact factor: 6.939

3.  Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer.

Authors:  Y Tokunaga; T Urano; K Furukawa; H Kondo; T Kanematsu; H Shiku
Journal:  Int J Cancer       Date:  1993-08-19       Impact factor: 7.396

4.  The estrogen receptor CpG island is methylated in most hematopoietic neoplasms.

Authors:  J P Issa; B A Zehnbauer; C I Civin; M I Collector; S J Sharkis; N E Davidson; S H Kaufmann; S B Baylin
Journal:  Cancer Res       Date:  1996-03-01       Impact factor: 12.701

5.  Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells.

Authors:  Y L Ottaviano; J P Issa; F F Parl; H S Smith; S B Baylin; N E Davidson
Journal:  Cancer Res       Date:  1994-05-15       Impact factor: 12.701

6.  Progesterone and estrogen receptors as prognostic variables in breast cancer.

Authors:  B H Mason; I M Holdaway; P R Mullins; L H Yee; R G Kay
Journal:  Cancer Res       Date:  1983-06       Impact factor: 12.701

7.  Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.

Authors:  S M Thorpe; C Rose; B B Rasmussen; H T Mouridsen; T Bayer; N Keiding
Journal:  Cancer Res       Date:  1987-11-15       Impact factor: 12.701

8.  Identification of a second human nm23 gene, nm23-H2.

Authors:  J A Stahl; A Leone; A M Rosengard; L Porter; C R King; P S Steeg
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

9.  Oestrogen and progesterone receptor expression influences DNA ploidy and the proliferation potential of breast cancer cells.

Authors:  M Andronas; S S Dlay; G V Sherbet
Journal:  Anticancer Res       Date:  2003 May-Jun       Impact factor: 2.480

10.  Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.

Authors:  R G Lapidus; A T Ferguson; Y L Ottaviano; F F Parl; H S Smith; S A Weitzman; S B Baylin; J P Issa; N E Davidson
Journal:  Clin Cancer Res       Date:  1996-05       Impact factor: 12.531

View more
  1 in total

Review 1.  Towards the Interpretability of Machine Learning Predictions for Medical Applications Targeting Personalised Therapies: A Cancer Case Survey.

Authors:  Antonio Jesús Banegas-Luna; Jorge Peña-García; Adrian Iftene; Fiorella Guadagni; Patrizia Ferroni; Noemi Scarpato; Fabio Massimo Zanzotto; Andrés Bueno-Crespo; Horacio Pérez-Sánchez
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.